Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 2
1973 1
1974 2
1975 1
1976 3
1977 1
1979 2
1981 1
1985 1
1988 3
1989 1
1997 1
1999 1
2002 3
2003 2
2004 2
2005 1
2007 2
2008 1
2009 2
2010 2
2011 2
2012 3
2013 1
2014 2
2015 2
2016 3
2019 1
2020 1
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
[Cirrhosis of the liver and HCV].
Hejda V. Hejda V. Vnitr Lek. 2015 Nov;61 Suppl 4:4s13-23. Vnitr Lek. 2015. PMID: 26667616 Review. Czech.
Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations.
Konstantinova AM, Michal M, Kacerovska D, Spagnolo DV, Stewart CJ, Kutzner H, Zelger B, Plaza JA, Denisjuk N, Hejda V, Shelekhova K, Bisceglia M, Danis D, Zamecnik M, Kerl K, Guenova E, Kazakov DV. Konstantinova AM, et al. Among authors: hejda v. Am J Dermatopathol. 2016 Aug;38(8):598-607. doi: 10.1097/DAD.0000000000000495. Am J Dermatopathol. 2016. PMID: 26863059 Free article.
[Quiscent trophoblastic disease].
Hron F, Hejda V, Feyereisl J, Safár P, Sochová H. Hron F, et al. Among authors: hejda v. Ceska Gynekol. 2011 Dec;76(6):443-6. Ceska Gynekol. 2011. PMID: 22312838 Czech.
Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics.
Skladaný L, Oltman M, Fraňková S, Dražilová S, Husa P, Šperl J, Hejda V, Urbánek P, Adamcová-Selčanová S, Janičko M, Kristian P, Kupčová V, Rác M, Schréter I, Virág L, Liptáková A, Ondrášová M, Jarčuška P. Skladaný L, et al. Among authors: hejda v. Int J Public Health. 2020 Dec;65(9):1723-1735. doi: 10.1007/s00038-020-01496-y. Epub 2020 Oct 10. Int J Public Health. 2020. PMID: 33040165
52 results